Author:
Mao Shanhong,Li Shiyou,Zhang Yuxin,Long Luoxin,Peng Junfeng,Cao Yuanyan,Mao Jessica Z.,Qi Xin,Xin Qi,San Guoliang,Ding Jing,Jiang Jun,Bai Xuejiao,Wang Qianting,Xu Pengfei,Xia Huan,Lu Lijun,Xie Liangzhi,Kong Desheng,Zhu Shuangli,Xu Wenbo
Funder
Beijing Municipal Science and Technology Commission
Subject
Pharmaceutical Science,General Materials Science,Biomedical Engineering,Bioengineering,Biotechnology
Reference58 articles.
1. COVID-19 mRNA vaccines;Huang;J. Genet. Genom.,2021
2. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies;Collier;Nature,2021
3. Evidence of escape of SARS-CoV-2 variant B. 1.351 from natural and vaccine-induced sera;Zhou;Cell,2021
4. Neutralising antibody activity against SARS-CoV-2 VOCs B. 1.617. 2 and B. 1.351 by BNT162b2 vaccination;Wall;Lancet,2021
5. Indian SARS-CoV-2 genomics consortium (INSACOG), genotype to phenotype Japan (G2P-Japan) consortium, CITIID-NIHR BioResource COVID-19 Collaboration;Mlcochova;SARS-CoV-2 B. 1. 617. 2 Delta Var. Replica Immune Evas., Nat.,2021
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献